| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | -0.073 | 0.04 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | -0.064 | 0.04 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | -0.074 | 0.04 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.04 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.092 | 0.04 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.12 | 0.04 |
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | -0.072 | 0.05 |
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.071 | 0.05 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.05 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.12 | 0.05 |